Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-03 02:13 | 2024-07-01 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $9.31 | 10,000 | $93,141 | 180,339 | -5.3% |
| 2024-06-06 23:15 | 2024-06-04 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $8.01 | 10,000 | $80,092 | 170,200 | -5.5% |
| 2024-05-31 23:50 | 2024-05-29 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | OPT+S | $8.73 | 72,952 | $636,703 | 209,793 | -25.8% |
| 2024-05-30 02:38 | 2024-05-28 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remark | Pharmaceutical Preparations | SALE | $9.01 | 1,775 | $15,988 | 188,508 | -0.9% |
| 2024-05-21 00:12 | 2024-05-17 | ARQT | Arcutis Biotherapeutics Inc. | Edwards Larry Todd | Officer; SVP Chief Commercial Officer | Pharmaceutical Preparations | SALE | $8.98 | 7,640 | $68,582 | 140,360 | -5.2% |
| 2024-05-03 23:29 | 2024-05-02 | ARQT | Arcutis Biotherapeutics Inc. | Moore Matthew Richard | Officer; SVP and Chief Business Officer | Pharmaceutical Preparations | SALE | $8.74 | 4,681 | $40,902 | 145,505 | -3.1% |
| 2024-05-03 23:22 | 2024-05-02 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $8.74 | 13,783 | $120,433 | 860,750 | -1.6% |
| 2024-05-03 23:22 | 2024-05-02 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remark | Pharmaceutical Preparations | SALE | $8.74 | 5,016 | $43,829 | 185,408 | -2.6% |
| 2024-05-03 23:22 | 2024-05-02 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $8.74 | 9,555 | $83,490 | 259,745 | -3.5% |
| 2024-03-07 01:14 | 2024-03-04 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remark | Pharmaceutical Preparations | SALE | $11.12 | 3,760 | $41,816 | 190,424 | -1.9% |
| 2024-03-07 01:09 | 2024-03-04 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $11.12 | 14,903 | $165,739 | 874,533 | -1.7% |
| 2024-03-07 01:08 | 2024-03-04 | ARQT | Arcutis Biotherapeutics Inc. | Moore Matthew Richard | Officer; SVP and Chief Business Officer | Pharmaceutical Preparations | SALE | $11.12 | 3,468 | $38,568 | 146,020 | -2.3% |
| 2024-03-07 01:12 | 2024-03-04 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $11.12 | 4,782 | $53,182 | 269,300 | -1.7% |
| 2024-03-07 00:28 | 2024-03-04 | ARQT | Arcutis Biotherapeutics Inc. | Heron Patrick J | Director | Pharmaceutical Preparations | BUY | $9.50 | 21,052 | $199,994 | 8,785,284 | +0.2% |
| 2024-03-02 00:11 | 2024-02-28 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $10.60 | 2,465 | $26,129 | 889,436 | -0.3% |
| 2024-01-04 01:30 | 2024-01-02 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $3.54 | 1,325 | $4,692 | 57,032 | -2.3% |
| 2023-12-02 04:51 | 2023-05-31 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | BUY | $6.38 | 1,463 | $9,334 | 515,145 | +0.3% |
| 2023-11-22 01:47 | 2023-11-21 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remark | Pharmaceutical Preparations | SALE | $1.98 | 1,850 | $3,661 | 46,634 | -3.8% |
| 2023-10-26 23:09 | 2023-10-24 | ARQT | Arcutis Biotherapeutics Inc. | Frazier Life Sciences VIII, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $2.50 | 80,000 | $200,000 | 8,764,232 | +0.9% |
| 2023-08-22 19:24 | 2023-08-21 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $7.04 | 1,605 | $11,302 | 58,357 | -2.7% |
| 2023-06-03 03:31 | 2023-05-31 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remark | Pharmaceutical Preparations | SALE | $7.80 | 1,830 | $14,278 | 42,146 | -4.2% |
| 2023-04-19 02:00 | 2023-04-17 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $13.97 | 8,500 | $118,728 | 165,825 | -4.9% |
| 2023-04-10 23:13 | 2023-04-06 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $12.01 | 8,500 | $102,085 | 165,825 | -4.9% |
| 2023-03-09 00:29 | 2023-03-06 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $15.26 | 2,435 | $37,167 | 366,657 | -0.7% |
| 2023-03-09 00:29 | 2023-03-06 | ARQT | Arcutis Biotherapeutics Inc. | Burrows Scott L | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $15.26 | 291 | $4,442 | 59,115 | -0.5% |
| 2023-03-09 00:26 | 2023-03-06 | ARQT | Arcutis Biotherapeutics Inc. | Turney Patricia A. | Officer; SVP, Operations | Pharmaceutical Preparations | SALE | $15.26 | 831 | $12,684 | 62,862 | -1.3% |
| 2023-03-09 00:25 | 2023-03-06 | ARQT | Arcutis Biotherapeutics Inc. | Lock Kenneth A. | Officer; Chief Commercial Officer | Pharmaceutical Preparations | SALE | $15.26 | 831 | $12,684 | 63,429 | -1.3% |
| 2023-03-09 00:28 | 2023-03-06 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $15.26 | 851 | $12,989 | 59,962 | -1.4% |
| 2023-03-09 00:26 | 2023-03-06 | ARQT | Arcutis Biotherapeutics Inc. | OSBORNE DAVID W | Officer; Chief Technical Officer | Pharmaceutical Preparations | SALE | $15.26 | 690 | $10,532 | 268,854 | -0.3% |
| 2023-03-07 02:54 | 2023-03-02 | ARQT | Arcutis Biotherapeutics Inc. | Moore Matthew Richard | Officer; See Remarks | Pharmaceutical Preparations | SALE | $15.83 | 1,610 | $25,481 | 11,690 | -12.1% |
| 2023-03-07 02:52 | 2023-03-02 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remarks | Pharmaceutical Preparations | SALE | $15.83 | 1,434 | $22,696 | 18,101 | -7.3% |
| 2023-03-07 02:51 | 2023-03-02 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $15.83 | 1,751 | $27,713 | 39,813 | -4.2% |
| 2023-03-03 03:07 | 2023-02-28 | ARQT | Arcutis Biotherapeutics Inc. | Turney Patricia A. | Officer; SVP, Operations | Pharmaceutical Preparations | SALE | $15.96 | 2,368 | $37,796 | 45,693 | -4.9% |
| 2023-03-03 03:06 | 2023-02-28 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $15.93 | 7,815 | $124,484 | 369,092 | -2.1% |
| 2023-03-03 03:05 | 2023-02-28 | ARQT | Arcutis Biotherapeutics Inc. | Burrows Scott L | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $15.90 | 1,850 | $29,421 | 38,406 | -4.6% |
| 2023-03-03 03:04 | 2023-02-28 | ARQT | Arcutis Biotherapeutics Inc. | Lock Kenneth A. | Officer; Chief Commercial Officer | Pharmaceutical Preparations | SALE | $15.96 | 2,368 | $37,796 | 43,260 | -5.2% |
| 2023-03-03 03:03 | 2023-02-28 | ARQT | Arcutis Biotherapeutics Inc. | OSBORNE DAVID W | Officer; Chief Technical Officer | Pharmaceutical Preparations | SALE | $15.96 | 2,005 | $32,002 | 254,644 | -0.8% |
| 2023-02-21 15:20 | 2023-02-15 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $16.98 | 8,500 | $144,352 | 165,825 | -4.9% |
| 2023-02-16 03:09 | 2023-02-13 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $17.01 | 1,000 | $17,012 | 376,907 | -0.3% |
| 2023-02-04 00:26 | 2023-02-01 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $17.00 | 1,000 | $17,003 | 377,907 | -0.3% |
| 2023-01-19 04:18 | 2023-01-17 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $13.72 | 8,500 | $116,655 | 165,825 | -4.9% |
| 2023-01-05 01:15 | 2023-01-03 | ARQT | Arcutis Biotherapeutics Inc. | Burnett Patrick | Officer; See Remarks | Pharmaceutical Preparations | SALE | $15.01 | 1,475 | $22,136 | 41,564 | -3.4% |
| 2022-12-10 00:47 | 2022-12-07 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $17.06 | 1,000 | $17,060 | 378,907 | -0.3% |
| 2022-11-23 03:06 | 2022-11-21 | ARQT | Arcutis Biotherapeutics Inc. | Matsuda Masaru | Officer; See Remark | Pharmaceutical Preparations | SALE | $18.19 | 1,720 | $31,289 | 19,535 | -8.1% |
| 2022-11-18 00:29 | 2022-11-15 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | OPT+S | $20.01 | 3,403 | $68,103 | 165,825 | -2.0% |
| 2022-11-10 00:39 | 2022-11-07 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; See Remarks | Pharmaceutical Preparations | SALE | $18.00 | 1,000 | $18,004 | 379,907 | -0.3% |
| 2022-10-12 01:47 | 2022-10-07 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | SALE | $19.51 | 1,000 | $19,510 | 380,907 | -0.3% |
| 2022-10-06 23:26 | 2022-10-04 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $20.29 | 6,000 | $121,766 | 168,208 | -3.4% |
| 2022-09-10 00:10 | 2022-09-07 | ARQT | Arcutis Biotherapeutics Inc. | Watanabe Todd Franklin | Director, Officer; President and CEO | Pharmaceutical Preparations | SALE | $21.51 | 1,000 | $21,510 | 381,907 | -0.3% |
| 2022-08-18 00:06 | 2022-08-15 | ARQT | Arcutis Biotherapeutics Inc. | Welgus Howard G. | Director | Pharmaceutical Preparations | SALE | $24.80 | 6,000 | $148,789 | 174,208 | -3.3% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.